Pros-IT CNR: an Italian prostate cancer monitoring project

M. Noale, S. Maggi, W. Artibani, P.F. Bassi, F. Bertoni, S. Bracarda, G.N. Conti, R. Corvò, M. Gacci, P. Graziotti, S.M. Magrini, R. Maurizi Enrici, V. Mirone, R. Montironi, G. Muto, S. Pecoraro, A. Porreca, U. Ricardi, A. Tubaro, V. ZagonelF. Zattoni, G. Crepaldi, the Pros-IT CNR study group, A.R. Alitto, E. Ambrosi, A. Antonelli, C. Aristei, M. Barbieri, F. Bardari, L. Bardoscia, S. Barra, S. Bartoncini, U. Basso, C. Becherini, R. Bellavita, F. Bergamaschi, S. Berlingheri, A. Berruti, M. Borghesi, R. Bortolus, V. Borzillo, D. Bosetti, G. Bove, P. Bove, M. Brausi, A. Bruni, G. Bruno, E. Brunocilla, A. Buffoli, M. Buglione, C. Buttigliero, G. Cacciamani, M. Caldiroli, G. Cardo, G. Carmignani, G. Carrieri, E. Castelli, E. Castrezzati, G. Catalano, S. Cattarino, F. Catucci, D. Cavallini Francolini, O. Ceccarini, A. Celia, F. Chiancone, T. Chini, C. Cianci, A. Cisternino, D. Collura, F. Corbella, M. Corinti, P. Corsi, F. Cortese, L. Corti, C. de Nunzio, O. Cristiano, R. D’Angelillo, L. Da Pozzo, D. D’agostino, D. D’Andrea, M. Dandrea, M. De Angelis, O. De Cobelli, B. De Concilio, A. De Lisa, S. De Luca, A. De Stefani, C.L. Deantoni, C. Degli Esposti, A. Destito, B. Detti, N. Di Muzio, A. Di Stasio, C. Di Stefano, D. Di Trapani, G. Difino, S. Falivene, G. Farullo, P. Fedelini, I. Ferrari, F. Ferrau, M. Ferro, A. Fodor, F. Fontana, F. Francesca, F. Giulio, P. Frata, G. Frezza, P. Gabriele, M. Galeandro, E. Garibaldi, P. Gennari, A. Gentilucci, A. Giacobbe, L. Giussani, G. Giusti, P. Gontero, A. Guarneri, C. Guida, A. Gurioli, D. Huqi, C. Imbimbo, G. Ingrosso, C. Iotti, C. Italia, P. La Mattina, E. Lamanna, L. Lastrucci, G. Lazzari, F. Liberale, G. Liguori, R. Lisi, F. Lohr, R. Lombardo, J. Lovisolo, G.M. Ludovico, N. Macchione, F. Maggio, M. Malizia, G. Manasse, G. Mandoliti, G. Mantini, L. Marafioti, L. Marciello, A.M. Marconi, A. Martillotta, S. Marzano, S. Masciullo, G. Maso, A. Massenzo, E. Mazzeo, L. Mearini, S. Medoro, R. Molè, G. Monesi, E. Montanari, F. Montefiore, G. Montesi, G. Morgia, G. Moro, G. Muscas, D. Musio, P. Muto, G. Muzzonigro, G. Napodano, C.L.A. Negro, M. Nidini, M. Ntreta, M. Orsatti, C. Palazzolo, I. Palumbo, A. Parisi, P. Parma, N. Pavan, M. Pericolini, F. Pinto, A. Pistone, V. Pizzuti, A. Platania, C. Polli, G. Pomara, E. Ponti, A.B. Porcaro, F. Porpiglia, D. Pugliese, A. Pycha, G. Raguso, A. Rampini, D.F. Randone, M. Roscigno, M.P. Ruggieri, G. Ruoppo, R. Sanseverino, A. Santacaterina, M. Santarsieri, R. Santoni, S. Scagliarini, G.V. Scagliotti, M. Scanzi, M. Scarcia, R. Schiavina, A. Sciarra, C. Sciorio, T. Scolaro, S. Scuzzarella, O. Selvaggio, A. Serao, S. Serni, M.A. Signor, M. Silvani, G. Silvano, F. Silvestris, C. Simeone, V. Simone, G. Spagnoletti, M.G. Spinelli, L. Squillace, V. Tombolini, M. Toninelli, L. Triggiani, A. Trinchieri, L.E. Trodella, L. Trodella, C. Trombetta, L. Tronnolone, M. Tucci, D. Urzì, R. Valdagni, M. Valeriani, M. Vanoli, E. Vitali, S. Zaramella, G. Zeccolini, G. Zini

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: The Pros-IT CNR project aims to monitor a sample of Italian males ≥18 years of age who have been diagnosed in the participating centers with incident prostate cancer, by analyzing their clinical features, treatment protocols and outcome results in relation to quality of life. Methods: Pros-IT CNR is an observational, prospective, multicenter study. The National Research Council (CNR), Neuroscience Institute, Aging Branch (Padua) is the promoting center. Ninety-seven Italian centers located throughout Italy were involved. The field study began in September 1, 2014. Subjects eligible were diagnosed with biopsy-verified prostate cancer, naïve. A sample size of 1500 patients was contemplated. A baseline assessment including anamnestic data, clinical history, risk factors, the initial diagnosis, cancer staging information and quality of life (Italian UCLA Prostate Cancer Index; SF-12 Scale) was completed. Six months after the initial diagnosis, a second assessment evaluating the patient’s health status, the treatment carried out, and the quality of life will be made. A third assessment, evaluating the treatment follow-up and the quality of life, will be made 12 months after the initial diagnosis. The 4th, 5th, 6th and 7th assessments, similar to the third, will be completed 24, 36, 48 and 60 months after the initial diagnosis, respectively, and will include also a Food Frequency Questionnaire and the Physical Activity Scale for the Elderly. Discussion: The study will provide information on patients’ quality of life and its variations over time in relation to the treatments received for the prostate cancer. © 2017, Springer International Publishing Switzerland.
Original languageEnglish
Pages (from-to)165-172
Number of pages8
JournalAging clinical and experimental research
Volume29
Issue number2
DOIs
Publication statusPublished - 2017

Keywords

  • Italian UCLA Cancer Index
  • Prostate cancer
  • Prostate cancer treatments
  • Quality of life
  • SF-12 Scale
  • adult
  • Article
  • clinical feature
  • follow up
  • food frequency questionnaire
  • genital system disease assessment
  • human
  • major clinical study
  • male
  • observational study
  • prospective study
  • prostate cancer
  • quality of life
  • risk factor
  • Short Form 12
  • UCLA Prostate Cancer Index
  • young adult
  • aged
  • biopsy
  • cancer staging
  • clinical trial
  • disease management
  • health status
  • Italy
  • middle aged
  • multicenter study
  • pathology
  • procedures
  • Prostatic Neoplasms
  • psychology
  • statistics and numerical data
  • Adult
  • Aged
  • Biopsy
  • Disease Management
  • Health Status
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prospective Studies
  • Quality of Life

Fingerprint

Dive into the research topics of 'Pros-IT CNR: an Italian prostate cancer monitoring project'. Together they form a unique fingerprint.

Cite this